Informations sur le produit
Nom :
GW1929
Synonymes :
- (S)-2-((2-Benzoylphenyl)amino)-3-(4-(2-(methyl(pyridin-2-yl)amino)ethoxy)phenyl)propanoic acid
- <span class="text-smallcaps">L</span>-Tyrosine, N-(2-benzoylphenyl)-O-[2-(methyl-2-pyridinylamino)ethyl]-
- Gw-1929
- N-(2-Benzoylphenyl)-O-[2-(methyl-2-pyridinylamino)ethyl]-<span class="text-smallcaps">L</span>-tyrosine
- N-(2-Benzoyphenyl)-O-[2-[N-methyl-N-(2-pyridinyl)amino]ethyl]-L-tyrosine
- O-{2-[methyl(pyridin-2-yl)amino]ethyl}-N-[2-(phenylcarbonyl)phenyl]-L-tyrosine
Description :
GW1929 is a drug that inhibits the production of prostaglandin J2 and hence has anti-inflammatory properties. It also blocks voltage-dependent calcium channels, which are involved in the propagation of pain signals. GW1929 is an agonist for PPARγ, which regulates transcriptional factors. It can be used for the treatment of cancer in humans and animals. GW1929 has been shown to block signal pathways involved in the development of cancer cells and to inhibit tumor formation in rodents. In addition, it has been shown to have an effect on body weight, energy metabolism, and cellular differentiation. The drug also inhibits mitochondrial membrane potential and pparγ expression in rat adipocytes.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
495.57 g/mol
Formule :
C30H29N3O4
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
